Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination

By Matsuo K.   Iwasaki T.   Asanuma H.   Yoshikawa T.   Chen Z.   Tsujimoto H.   Kurata T.   Tamura S.-I.S.-i.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1344-1350

Elsevier

Access to resources Recommend Favorite

Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration

By Asanuma H.   Koide F.   Suzuki Y.   Nagamine T.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin

By Tamura S.-i.   Hatori E.   Tsuruhara T.   Aizawa C.   Kurata T.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite